The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.
Remember ARRIVE, ASCEND, and ASPREE–the 3 pivotal randomized controlled trials conducted in nearly 50,000 patients in a variety of possible scenarios that changed the place of aspirin in primary cardiovascular disease prevention for good?
Try this 8-question quiz as a refresher on the study outcomes, the recommendations and patient selection for aspirin use in primary prevention of CVD.
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.